Angiogenic factors have an essential role in normal and pathologic angiogenesis. However, the clinical implication of angiogenic factor expression in myelodysplastic syndromes (MDS) remains unclear.
Publication
British journal of cancer, 2011, Vol 105, Issue 7, p975